A Tailored, Health Communication Intervention for HPV Vaccine Hesitant Families
Status unconfirmed · Not applicable
Conditions studied: Human Papilloma Virus, HPV-Related Carcinoma, Vaccine Refusal, Parents, Program, Communication
In brief
The human papillomavirus (HPV) causes 90% of cervical cancers and is implicated in multiple other cancers. The HPV vaccine can prevent the vast majority of these cancers, but it is underused in adolescents, especially among those within vaccine hesitant (VH) parents. The proposed research is to develop and pilot test a tailored, health communication intervention aimed to increase HPV vaccination among VH parents. The proposed research is innovative because no evidence-based health communication interventions target HPV VH parents, and we will use stakeholder engagement throughout this study. The research will add knowledge on how tailored education provided before a doctor's visit can play a role in improving HPV vaccination rates among underserved, VH parents.
Key facts
- Study ID
- NCT04380623
- Run by
- Meharry Medical College
- People needed
- 244
- Starts
- 2021-02-15
- Expected to finish
- 2024-05-30
- Last updated by the study team
- 2021-09-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Parents
- Parents of patients of MMC Pediatrics aged 11-18
- Refused HPV vaccination in the past two years
- Have not received any doses of HPV vaccine
- Own smartphone
- Speak English
- Have a clinic appointment scheduled within the coming month (AIM 1 Stage 2 \& AIM 2 only)
- Did not participate in Aim 1 Stage 1 (AIM 1 Stage 2 only)
- Did not participate in Aim 1 Stage 1 or Aim 1 Stage 2 (Aim 2 only)
- Providers
- Physicians, physician assistants, and nurse practitioners who deliver primary care to patients aged 11-18 (Aim 1 Stage 1)
- Physicians, physician assistants, and nurse practitioners who deliver primary care to patients aged 11-18 and the intervention at Meharry Medical College. (Aim 1 Stage 2, Aim 2)
You may not qualify if…
- Parents
- Parents with vaccinated patients or never been offered the vaccine in MMC pediatrics aged 11-18
- Unvaccinated yet never refused the vaccine
- Do not speak English
- Do not own a smart phone
- Does not have an upcoming clinic visit (Aim 1 Stage 2 and Aim 2)
- Providers
- Providers: Physicians, nurse practitioners, and physician assistants who do not deliver primary care to pediatric patients aged 11-18 at Meharry and other clinics
- Providers who do not provide the HPV vaccine.
- Providers who do not participate in Aim 1 stage 1 (Aim 1 Stage 2 only)
- Did not pilot study (Aim 2)
Where it is running
- Meharry Medical College — Nashville, Tennessee, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.